Position in DSGN
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$247,528
-$9,914 QoQ
Shares Held
23,264
-15.2% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,555,077,811 across 347 Biotechnology names. DSGN ranks #284 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in DSGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $247,528 | 23,264 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $257,442 | 27,446 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $180,018 | 23,907 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $82,985 | 24,625 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $85,559 | 22,166 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $216,936 | 35,160 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $198,042 | 36,811 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $108,150 | 32,284 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $182,949 | 45,397 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $228,794 | 86,338 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $115,013 | 48,735 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $490,631 | 77,878 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $324,521 | 56,243 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,035,522 | 295,860 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,118,383 | 66,889 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $391,650 | 27,975 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $923,763 | 57,199 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,176,200 | 54,937 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $464,644 | 31,630 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $127,334 | 6,402 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $646,467 | 21,621 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||